Eli Lilly & Co. vs Tenet Healthcare Corporation New
LLY vs THC — side-by-side comparison from reported financials. LLY leads 9, THC leads 2 of 11 comparable metrics.
Eli Lilly & Co.
LLY · Healthcare
$1 177.20+0.65%Solid
Tenet Healthcare Corporation New
THC · Healthcare
$264.31+1.44%Mixed
| Metric | LLY | THC |
|---|---|---|
| Price | $1 177.20 | $264.31 |
| Market cap | $1.05T | $21.3B |
| Revenue (TTM) | $79.7B | $21.8B |
| Revenue growth | +31.7% | +3.6% |
| Net margin | 33.5% | 10.3% |
| Free cash flow | $18.2B | $3.02B |
| Net cash (debt) | ($35.2B) | ($10.3B) |
| 1-year price return | +37.6% | +35.6% |
| P/E | 41.6 | 9.5 |
| P/E vs own history (cheap-side %) | 88% | 50% |
| Dividend yield | 0.52% | — |
| Return on equity | 93% | 51% |
| Altman Z-score | 7.10 | 1.51 |
| CV checks passed | 11 of 11 | 9 of 11 |
| Employees | 50,000 | 99,000 |
Full résumé-style profiles: LLY CV · THC CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.